Closed-loop blood glucose control systems and methods
US11484652B2 · kind B2 · utility
1Cited by
115References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 1, 2018 |
| Grant date | Nov 1, 2022 |
| Priority date | — |
| Expiry date | Aug 26, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2230/201
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
An automated closed-loop blood glucose control system comprises a continuous glucose-monitoring sensor (101), a subcutaneous insulin delivery device (103); and a controller (105) which determines a maximal allowable insulin injection amount and determines an insulin delivery control signal on the basis of the maximal allowable insulin injection amount and the quantity of insulin to inject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.